Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 770 of 6351
-
Can a single shot keep tetanus at bay?
Prevention CompletedThis is a randomized, observer-blind, positive-controlled study. There will be 2 treatment groups, Subjects who gave informed consent and passed the questioning screen were randomly assigned 1:1 to be immunized with 1 dose of Tetanus Vaccine, Adsorbed (TTVA) or control vaccine.
Phase 3 • Sponsor: CanSino Biologics Inc. • Aim: Prevention
Last updated Aug 07, 2026 00:00 UTC
-
New drug cocktail targets melanoma brain metastases in early trial
Disease control Recruiting nowThe goal of this interventional clinical trial is to provide proof-of-principle data for the biologic activity of defactinib in combination with avutometinib in brain metastases from melanoma, and to define the potential role of the combination with mutant BRAF inhibitors or afte…
Phase 1/2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a single shot before surgery shield your heart?
Prevention Recruiting nowThis is an investigator initiated, multi-center, open-labelled, superiority randomized controlled trial of 372 patients undergoing elective non-cardiac surgery. Recruited patients will be randomized in a 2:1 ratio to receive single subcutaneous dose of Glucagon-like Peptide-1 Rec…
Phase 4 • Sponsor: The University of Hong Kong • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Hair tests could reveal hidden use of 'Date Rape' drug GHB
Knowledge-focused CompletedAccording to the media, GHB is the main substance used for chemical submission. The national survey conducted by the Addictovigilance centre of Paris on drug-facilitated assaults shows that GHB is used, but only in a very small proportion of cases. However, the short detection ti…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Laser resurfacing may shield aging skin from cancer
Prevention Recruiting nowThe purpose of this study is to determine if the Fractionated Laser Resurfacing (FLR) procedure can protect one forearm/wrist from precancerous actinic keratosis (AKs) as well as prevent skin cancer in older subjects with active AKs. This study builds on a similar study ongoing a…
Sponsor: Wright State University • Aim: Prevention
Last updated Jul 18, 2026 00:00 UTC
-
New combo shot CagriSema shows promise for diabetes and weight loss
Disease control CompletedThis study will look at how much CagriSema helps participants with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new investigational medicine. Doctors may not yet prescribe CagriSema. CagriSema will be compared to a "dummy" medicine (also called "placebo…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Gene-Editing hope for thalassemia patients: early trial launched
Disease control By invitation onlyThe goal of this open label, single-arm clinical study is to learn about the safety and efficacy of CS-101 in treating β-thalassemia.
Early phase 1 • Sponsor: CorrectSequence Therapeutics Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Virtual fitness for aging hearts: a new frontier in cardiac rehab?
Disease control CompletedThis pilot study will assess the feasibility and generate preliminary efficacy data of a novel, synchronous, home-based exercise training program for rural older adults with cardiovascular disease (CVD) using Vivo, an online, live, small group fitness program developed for older …
Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Engineered immune cells aim to clear leukemia before transplant
Disease control Recruiting nowThis study is designed as a single arm open label traditional Phase I, 3+3, study of CD4-redirected chimeric antigen receptor engineered T-cells (CD4CAR) in subjects with relapsed or refractory AML. The study will evaluate safety in this subject population and also the presence o…
Phase 1 • Sponsor: Huda Salman • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug TAK-279 targets rare, severe psoriasis in phase 3 trial
Disease control CompletedThe main aim of this study is to check if TAK-279 improves symptoms of With Generalized Pustular Psoriasis (GPP) or Erythrodermic Psoriasis (EP) and side effect from the study treatment or TAK-279. All participants will be assigned to study treatments of TAK-279 and will be trea…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New triple therapy takes on pancreatic cancer
Disease control Recruiting nowTo evaluate the efficacy and safety of TQB2868 injection combined with anlotinib capsule and chemotherapy in treated patients with Pancreatic Neoplasms
Phase 2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:59 UTC
-
Could a wakefulness drug lift depression? new trial tests solriamfetol
Symptom relief CompletedPARADIGM (Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol) is a Phase 3, randomized, double-blind, placebo-controlled, multicenter trial to assess the safety and efficacy of solriamfetol for the treatment of major depressive disorder (MDD) in adu…
Phase 3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New antibody could reduce bleeding after stroke
Disease control Recruiting nowSISTER is a Phase-II, prospective, randomized, placebo-controlled, blinded, dose finding trial that aims to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in acute ischemic stroke.
Phase 2 • Sponsor: Translational Sciences, Inc. • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New weekly shot shows promise for obesity weight loss
Disease control CompletedThis study will look at how a new medicine called NNC0519-0130 helps people with excess body weight lose weight. The study will test up to 6 different doses of NNC0519-0130. Participants will take 1-2 injections once a week. The study medicine will be injected under skin with a t…
Phase 2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can a nutrient in eggs keep malnourished kids from getting worse?
Disease control OngoingThe goal of this clinical trial is to test choline supplementation in children with moderate acute malnutrition in Malawi. The main question it aims to answer is: Will provision of RUSF with added choline (500mg/day) throughout treatment of moderate acute malnutrition (up to 12 …
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Smart bracelets could shave minutes off stroke treatment time
Disease control CompletedThis study intends to construct the goal-oriented integrated intervention model through the intelligent bracelet automatic positioning and feedback system based spatiotemporal computing technology (FAST model) to promote the reconstruction of workflow in stroke centers and to sho…
Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
India study aims to match depression patients to best therapy or drug
Disease control OngoingThe OptimizeD study aims to improve outcomes in depression in primary care in India. This study will randomize 1500 patients with moderate to severe depression to either psychotherapy based on behavioral activation called the Healthy Activity Program (HAP) or antidepressant medic…
Phase 3 • Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New surgery aims to stop arm swelling after breast cancer treatment
Prevention Recruiting nowThis study aims to evaluate the effectiveness of the Lymphovenous Bypass (LVB) procedure compared to physiotherapy alone as secondary prevention of lymphedema in breast cancer patients undergoing axillary lymph node dissection.
Sponsor: Dharmais National Cancer Center Hospital • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
New gel could slash facial skin cancers in rare genetic condition
Disease control OngoingThe aim of this clinical study is to find out how well Patidegib Gel 2% works in preventing new basal cell carcinomas (BCCs) developing on the face of adults with Gorlin syndrome, and how safe Patidegib Gel 2% is to use. People who take part will apply either Patidegib Gel 2% or…
Phase 3 • Sponsor: Sol-Gel Technologies, Ltd. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could earlier aspirin save lives in sickle cell pregnancies?
Disease control OngoingThis study is being conducted to evaluate the safety and effect of starting daily use of low dose (100 mg) aspirin in pregnant women with sickle cell disease, who are being followed in two county hospitals in Angola, in the first trimester versus the second trimester of the gesta…
Phase 1/2 • Sponsor: Instituto Nacional de Investigacao em Saude, Angola • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC